Our ObAdEx biotherapy project labeled by Eurobiomed
ObAdEx, our innovative biotherapy product in development for chronic metabolic diseases associated to obesity, gets labelled by Eurobiomed, the healthtech growth accelerator of South of France. Eurobiomed highlights our breakthrough and innovative approach as well as our tailored preclinical developmental plan to de-risk critical bioproduction steps before first-in-patients trials. ExAdEx-Innov is currently leading a fundraising […]
ExAdEx-Innov awarded Innovative Company of 2022 in Côte d’Azur
ExAdEx-Innov has been awarded « Innovative Company of 2022 » by the Metropolitan Region Nice Côte d’Azur . We are happy and proud to receive this award for our activities and our ObAdEx project in particular, and be recognized as the most promising innovative entrepreneurial project emerging from the local research excellence! To read more (in French): […]
ExAdEx-Innov joins iBV Bioincubator
We are very proud to integrate the Bio-Incubator of the Institut de Biologie Valrose – iBV to allow our growth in a scientific environment of excellence and support for deeptech innovation.Thank you to all our historical and current supports, CNRS – Centre national de la recherche scientifique CNRS Innovation, SATT Sud-Est, Incubateur Paca-Est, Eurobiomed, Métropole […]